from Wiktionary, Creative Commons Attribution/Share-Alike License

  • n. A particular cephalosporin antibiotic.


Sorry, no etymologies found.


  • "This is serious for Basilea," Chief Financial Officer Ronald Scott said during a conference call Tuesday, pointing to the absence of expected milestone payments and royalties for ceftobiprole, which is also known as Zevtera.

    Swiss Firm Files Claim Against J&J

  • There is a high unmet medical need for new antibiotics such as ceftobiprole that cover resistant bacteria including MRSA, but also clinically important and problematic Gram-negative pathogens. Aktuelle Nachrichten

  • Johnson, its development partner for its key drug ceftobiprole, handed back full rights for the drug after European regulators rejected it.

    J Cedes Drug Rights To Small Swiss Partner

  • Johnson confirmed that it had terminated its rights to ceftobiprole but didn't provide financial details.

    J Cedes Drug Rights To Small Swiss Partner

  • European health-care regulators had halted the approval process on ceftobiprole, pending completion of investigations into how clinical testing was conducted.

    J Cedes Drug Rights To Small Swiss Partner

  • There is currently a fifth generation of cephalosporins on which researchers pin great hope, exemplified by the drug ceftobiprole.


  • The ruling ends a dispute between the two companies over experimental antibiotic ceftobiprole, a drug that targets so-called superbugs, which are responsible for many hospital-acquired-infection deaths.

    Business Watch

  • A European Union regulatory committee delayed its decision on whether to approve Zevtera, or ceftobiprole, for the treatment of complicated skin and soft tissue infections.

    Europe Ends Lower as Insurers, Autos Slide

  • Basilea Pharmaceutica AG said it filed an arbitration claim against U.S. partner Johnson & Johnson over delays in launching the antibiotic drug ceftobiprole, which have put on hold a potentially vital source of revenue for the tiny Swiss biotech firm and triggered a steep slide in its share price.

    Swiss Firm Files Claim Against J&J

  • The FDA's letter came as a surprise, since the regulator in February said it wouldn't hold a previously scheduled advisory-committee meeting on ceftobiprole, leading some analysts to believe the drug would gain approval without delay.

    Planned 'superbug' antibiotic hits U.S. snag


Log in or sign up to get involved in the conversation. It's quick and easy.